What is the Future of Kadcyla in Cancer Treatment?
Ongoing research is focused on expanding the use of Kadcyla to other HER2-positive cancers and improving its efficacy through combination with other therapies. Studies are also exploring biomarkers that can predict which patients are most likely to benefit from Kadcyla, allowing for more personalized treatment approaches. The development of new ADCs with different payloads and targeting mechanisms is another exciting avenue that could enhance the therapeutic landscape for cancer patients.
